CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to YMAB

humanized anti-GD2 antibody

Phase 2
Y-mAbs Therapeutics, Inc. (YMAB)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Jul '27
YMABPhase 2

humanized anti-GD2 antibody Phase 2 Est. Readout

humanized anti-GD2 antibody
Jul 2027~
CT.gov
00%
Competitive Landscape

0 competitors in Recurrent Osteosarcoma

View Full Landscape
Drug Information

Target Indication

Recurrent Osteosarcoma

Clinical Trial

NCT02502786

Last updated: 8/15/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.